House of Commons · Written Ministerial Statement
DHSC Annual Accounts – COVID-19 reporting
11 December 2025 · Department of Health and Social Care
Proposed by Ashley Dalton Lab West Lancashire
Summarised by AI from the official record, so it can contain mistakes.
At a glance
Key points
- The Department of Health and Social Care published its annual report for 2024-25.
- Financial losses exceed 2 billion due to expired COVID-19 inventory.
- The losses include medicines, vaccines, testing kits, PPE, and quarantine service debts.
Issue summary
The statement discusses the publication of the Department of Health and Social Care's (DHSC) annual report for 2024-25, which includes financial losses related to expired COVID-19 inventory.
Action requested
The DHSC is disclosing losses from expired COVID-19 medicines, vaccines, testing kits, personal protective equipment (PPE), and managed quarantine service debts as required by HM Treasury’s ‘Managing Public Money’ guidance. These losses amount to over £2 billion in total.
Key facts
- The annual report was published on 11 December 2025.
- Losses from two COVID-19 antiviral medicines totalled £856 million and £393 million respectively.
- A loss of £527 million relates to 19,285,820 doses of expired vaccines.
- Testing kits accounted for a loss of £0.7 million (547,420 units).
- The DHSC is waiving or abandoning claims to the value of £572 million against PPE suppliers.
- A loss of £16.7 million was disclosed in relation to debts arising from the managed quarantine service.